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Abstract: OWR is a genetic disease, transmitted as an autosomal dominant disorder characterized by arteriovenous malformations pre-
dominantly involving the mucocutaneous epithelium. One of the significant complications is the development of arteriovenous fistulas 
in different organs like the liver and brain. One of the rarest complications of this arteriovenous conduit is a high-output heart failure. 
We would like to describe a 66 years old woman who was admitted with a high-output cardiac failure who deteriorated clinically and 
was treated successfully by conservative management.
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A 66 year old woman was admitted with dyspnea at 
rest. This symptom started a few months ago as short-
ness of breath during exercise and got worse with time. 
In the last week she could not sleep at night due to 
shortness of breath with orthopnea. She had a family 
history  of  Heretidary  Hemorrhagic  Telangiectasia 
(HHT), and was hospitalized a few years ago with 
epistaxis, gastrointestinal bleeding, and she also had 
a hemorrhagic stroke. During hospitalization in 2007 
(when she was admitted with gastrointestinal bleeding) 
teleangiectases were detected in the stomach.
On  physical  examination  telangiectases  were 
observed on the face, lips, hands, and on the nose. 
Heart sounds were normal with a holosystolic 2/6 
murmur  without  any  pathological  heart  sounds  or 
clicks. On auscultation there were mild to moderate 
wet rhonchi without wheezes. There was a +3 periph-
eral pitting edema in both legs.
Laboratory  results  showed  an  iron  deficiency 
anemia (Hemoglobin 10 g%) with elevated alkaline 
phosphatase and bilirubin levels with normal hepa-
tocellular liver enzymes, but with a prolonged pro-
thrombin time (INR-1.6).
Thyroid function tests were normal.
The electrocardiogram showed a normal sinus rhythm 
(70 beats per minute) with a normal P-R interval and 
a normal axis (60°). No signs of myocardial hyper-
trophy  or  signs  of  systolic  overlaod  were  observed. 
Echocardiography demonstrated a normal left and right 
ventricular  size  and  function  (Left Ventricular  Ejec-
tion  Fraction  65%–70%)  with  diastolic  dysfunction 
(restrictive pattern), mild dilatation of the aortic root and 
the ascending aorta with minimal aortic regurgitation. 
The Doppler study that evlauted her hepatic venous 
flow did not show any signs of left to right shunt within 
the liver or anywhere else around the liver.
Chest X-rays has demonstrated mild to moderate 
pulmonary edema.
During  hospitalization  she  was  treated  with 
diuretics and beta blockers (Normiten 50 mg once 
daily) and her symptoms improved altogether with 
weight loss of 5 Kg within 7 days. The orthopnea 
disappeared, and the dyspnea was relieved. She had 
no symptoms of heart failure.
Discussion
OWR (or HHT) occurs in 0.01% of the population. 
It is an autosomal dominant disease characterized by 
angiodysplastic lesions (telangiectases and arteriovenous 
malformations) that affect many organs, including the 
skin, lungs, gastrointestinal tract, and brain.1
The genes involved in HHT have been identified 
as endoglin (HHT type 1) on chromosome 9q33–34, 
and activin receptor (HHT type 2) on chromosome 
12q13. Both genes are involved with the regulation 
of  transforming  growth  factor  (TGF)  beta  signal-
ing pathway and expression, mainly aimed to endo-
thelial and vascular smooth muscle cells. Endoglin 
and ALK1  knockout  mice  die  between  embryonic 
days 9–11 due to vascular defects, demonstrating the 
importance of these proteins in angiogenesis.1,2 This 
disorder is clinically characterized by cutaneous and 
muco-cutaneous telangiectases, severe and recurrent 
epistaxis and gastrointestinal hemorrhage caused by 
teleangiectases of the nose and upper gastrointestinal 
tract. Patients also have arteriovenous shunts, most 
commonly found in the lungs, brain, and liver. Perti-
nent findings on physical examination in patients with 
liver involvement vary with the extent of the disease. 
Patients with small hepatic AVMs may have a normal 
examination  while  those  with  diffuse  involvement 
may  have  hepatomegaly.  Liver  function  tests  are 
mildly elevated in 75%. The most common labora-
tory findings are elevated alkaline phosphatase and 
bilirubin levels with normal hepatocellular enzymes 
with cholestasis. Angiographic findings include large, 
tortuous hepatic arteries, and dense, enlarged hepatic 
veins.
The heart failure syndrome in OWR patients is 
characterized  by  an  elevated  resting  cardiac  index 
beyond the normal range of 2.5–4.0 L/min/m2. The 
assumption is that ineffective blood volume and pres-
sure, chronic activation of the sympathetic nervous 
system and the rennin–angiotensin/aldosterone axis 
with increased serum vasopressin concentration cause 
chronic volume overload that gradually develops ven-
tricular enlargement, remodeling and heart failure.
The  definition  of  high–output  heart  failure  is 
defined by symptoms of heart failure-like dyspnea 
at rest or with varying degrees of exertion, orthop-
nea, paroxysmal nocturnal dyspnea, and pulmonary/
peripheral edema) in the presence of normal cardiac 
index.  The  elevated  cardiac  output  itself  does  not 
lead  to  symptoms  of  congestive  heart  failure. The 
prolonged increase in blood volume, the continuous 
increased right atrial pressure, the high pulmonary High-output heart failure
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artery  pressure—may  cause  an  increased  left 
ventricular end diastolic pressure with gradual myo-
cardial de-compensation.3,4
Medical therapy involves salt restriction, diuretics, 
antihypertensive agents, anti-arrhythmic agents, and 
digoxin as clinically indicated. The particular clinical 
manifestation of liver involvement in patients with 
hereditary  hemorrhagic  telangiectasia  may  depend 
on the predominant type and size of shunt as well as 
on the effects of an abnormal hepatic blood supply. 
The  majority  of  patients  with  liver  arteriovenous 
malformation/shunt have a hyperdynamic circulation 
resulting from arteriovenous shunting, portovenous 
shunting, or both. Practically all patients with high-
output cardiac failure have shunts from the hepatic 
artery to the hepatic veins. Chronic high flow from 
such shunts eventually leads to heart failure. Other 
factors related to diastolic dysfunction such as older 
age, hypertension, and coronary artery disease may 
play a part in precipitating heart failure.
Notably, as we found and as others reported—the 
clinical manifestations of liver involvement overlap 
and may fluctuate over time, with spontaneous exac-
erbations and remissions. The reason for spontaneous 
improvement is unclear. It may depend on changes 
in shunting patterns or on the presence of reversible 
conditions (e.g. anemia or atrial fibrillation). In some 
cases,  pregnancy,  which  causes  a  hyperdynamic 
circulatory state, has precipitated heart failure, with 
resolution after delivery.
conclusions
A woman with OWR disease was admitted with high 
output heart failure that was demonstrated by echo-
cardiography as a diastolic dysfunction with a restric-
tive pattern.
We would like to suggest that high output heart 
failure could be presented as a diastolic dysfunction 
and the management could be conservative.
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